Valiathan et al., 2016 (1), published an informative article on the aging of the immune system. The authors found that lymphocytes in the elderly, 70 to 92 years, were lower than in adults, 21 to 50 years. Neutrophils in the elderly were elevated. Cytokine IL-6 was also elevated in the elderly. Levels of lymphocytes, neutrophils, and IL-6 all have strong predictive value in the outcome of COVID-19.
Herold and colleagues, 2020 (2), showed that IL-6 at admission is predictive of progression to respiratory distress in COVID-19 patients. Above 80 pg/mL the predictive value for intubation was 92%.
From another article on this website:
Reduced lymphocytes counts and increased neutrophils to lymphocytes ratio (NLR) is a prominent feature of COVID-19. Higher NLRs are associated with poor outcomes.
With age, the immune system becomes senescent. From another article on this website:
The senescent immune system displays reduced responsiveness, and this has to be overcome if therapeutic vaccination is to be of benefit for the patient. Although the defects are quite well-characterized, the molecular mechanisms, inducing and sustaining immunosenescence and ways to overcome them, are still to be explored in more detail.
Given the above, it is interesting to learn how the levels of different elements involved in the immune response evolve throughout lifetime. Valiathan et al., 2016 (1), presented their relevant findings in a series of informative graphs that we share below.
For comparison, we insert below a table with characteristics of COVID-19 patients from a study from China (3). You can see that in COVID-19 patients with a mostly mild and moderate course of COVID-19, IL-6 levels are comparable to the levels recorded by Valiathan et al., 2016 (1), in the elderly.
The citation below explains how Valiathan et al., 2016 (1), obtained their data:
Subjects and samples. This study was conducted at the University of Miami-Miller School of Medicine by retrospectively analysing the data for complete blood count (CBC) components and circulating lymphocyte subsets from infant to elderly age groups to determine the changes as well as differences in these parameters. The protocols involving human subjects were approved by Institutional Review Board prior to conducting the research. The study was conducted on peripheral blood specimens from Group 1 (Gr1): infants (1 month to 7 months, n = 35), Group 2 (Gr2): children (1 year to 6 years, n = 27), Group 3 (Gr3): adolescents (12 years to 18 years, n = 36), Group 4 (Gr4): adults (21 years to 50 years, n = 60) and Group 5 (Gr5): elderly (70 years to 92 years, n = 33). The numbers of males and females were: infants (males: 18 and females: 17), children (males: 13 and females: 14), adolescents (males: 19 and females: 17), adults (males: 31 and females: 29) and elderly (males: 8 and females: 25). The age ranges for different study groups were derived based on previous reports [40–42]. All the participants were in good health without any pre-existing medical conditions and all adolescents, adults and elderly participants were non-smokers.
Selected references:
1. Valiathan et al. Scandinavian Journal of Immunology, 2016, 83, 255–266.
2. Herold T, Jurinovic V, Arnreich C, Hellmuth JC, von Bergwelt-Baildon M, Klein M, Weinberger T. Level of IL-6 predicts respiratory failure in hospitalized symptomatic COVID-19 patients. medRxiv 2020.04.01.20047381; doi: https://doi.org/10.1101/2020.04.01.20047381.
3. Tang Wei, Cao Zhujun, Han Mingfeng, Wang Zhengyan, Chen Junwen, Sun Wenjin et al. Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial BMJ 2020; 369 :m1849
1 Comment